article thumbnail

Revised Final Guidance on Nitrosamines Offers New Recommendations for Assessment and Control

FDA Law Blog

Nitrosamines are impurities that can form during drug manufacturing and are considered potentially potent carcinogens. It’s these varied scenarios that give quality managers nightmares. FDA recognizes that nitrosamine detection and remediation are complicated undertakings for quality managers.

article thumbnail

Interdisciplinary Case Report

CDOCS

Couple this with the in-office technologies of CEREC&reg; Primescan and CBCT allowed us to gain control of the technical processes necessary to manage and produce the surgical and restorative phases of treatment at one location.</span></p> We reviewed the 3D images together and discussed the risks associated with his case.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Urinary Incontinence Revisited: George Kuchel & Alison Huang

GeriPal

And that’s what makes these issues so challenging, because at one level, we use the same term to refer to that incredibly multifactorial, complicated, complex condition as we do to stress incontinence, which is also complex in its own way. We think of it really as a kind of a management tool as well. George 23:31 Sure.

IT 120
article thumbnail

An Arm and a Leg: The Prescription Drug Playbook, Part I

Physician's Weekly

Back in February, we asked you, our listeners, to tell us how you’ve managed when your prescriptions got really expensive. Claire: All of that, but the celebrity factor isn’t really what makes Cost Plus different: The company buys meds direct from manufacturers, and adds 15 percent to their wholesale cost.